EUGLYCAEMIC DIABETIC KETOACIDOSIS

This adverse event was reported 4133 times

EUGLYCAEMIC DIABETIC KETOACIDOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 EMPAGLIFLOZIN 2079 0.0299
1 EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 81 0.0275
2 EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE 87 0.0244
3 EMPAGLIFLOZIN AND LINAGLIPTIN 41 0.0209
4 ERTUGLIFLOZIN 21 0.0188
5 DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 49 0.0140
6 DAPAGLIFLOZIN 779 0.0129
7 CANAGLIFLOZIN 296 0.0099
8 SITAGLIPTIN PHOSPHATE 23 0.0084
9 METFORMIN HYDROCHLORIDE 431 0.0073
See all drugs enriched for association with EUGLYCAEMIC DIABETIC KETOACIDOSIS